130 related articles for article (PubMed ID: 6907088)
21. Animal models of copper-associated liver disease.
Fuentealba IC; Aburto EM
Comp Hepatol; 2003 Apr; 2(1):5. PubMed ID: 12769823
[TBL] [Abstract][Full Text] [Related]
22. Copper metabolism after living related liver transplantation for Wilson's disease.
Wang XH; Cheng F; Zhang F; Li XC; Qian JM; Kong LB; Zhang H; Li GQ
World J Gastroenterol; 2003 Dec; 9(12):2836-8. PubMed ID: 14669346
[TBL] [Abstract][Full Text] [Related]
23. Identification of the carrier of the Bedlington Terrier copper disease.
Owen CA; McCall JT
Am J Vet Res; 1983 Apr; 44(4):694-6. PubMed ID: 6869968
[TBL] [Abstract][Full Text] [Related]
24. Early cell transplantation in LEC rats modeling Wilson's disease eliminates hepatic copper with reversal of liver disease.
Malhi H; Irani AN; Volenberg I; Schilsky ML; Gupta S
Gastroenterology; 2002 Feb; 122(2):438-47. PubMed ID: 11832458
[TBL] [Abstract][Full Text] [Related]
25. Inherited copper toxicosis in Bedlington terriers: Wilson's disease (hepatolenticular degeneration).
Owen CA; Ludwig J
Am J Pathol; 1982 Mar; 106(3):432-4. PubMed ID: 7065120
[No Abstract] [Full Text] [Related]
26. A critical evaluation of copper metabolism in Indian Wilson's disease children with special reference to their phenotypes and relatives.
Prasad R; Kaur G; Walia BN
Biol Trace Elem Res; 1998 Nov; 65(2):153-65. PubMed ID: 9881519
[TBL] [Abstract][Full Text] [Related]
27. Metallothionein concentration in the liver of patients with Wilson's disease, primary biliary cirrhosis, and liver metastasis of colorectal cancer.
Mulder TP; Janssens AR; Verspaget HW; van Hattum J; Lamers CB
J Hepatol; 1992 Nov; 16(3):346-50. PubMed ID: 1487612
[TBL] [Abstract][Full Text] [Related]
28. [Genetic disorders of copper transport--diagnosis and new treatment for the patients of Wilson's disease].
Aoki T
No To Hattatsu; 2005 Mar; 37(2):99-109. PubMed ID: 15773321
[TBL] [Abstract][Full Text] [Related]
29. Copper metabolism in hypercupremic human livers. Studies of its subcellular distribution, association with binding proteins and expression of mRNAs.
Bingle CD; Srai SK; Epstein O
J Hepatol; 1992 May; 15(1-2):94-101. PubMed ID: 1506662
[TBL] [Abstract][Full Text] [Related]
30. Excess zinc associated with severe progressive cholestasis in Cree and Ojibwa-Cree children.
Phillips MJ; Ackerley CA; Superina RA; Roberts EA; Filler RM; Levy GA
Lancet; 1996 Mar; 347(9005):866-8. PubMed ID: 8622393
[TBL] [Abstract][Full Text] [Related]
31. Is copper incorporation to caeruloplasmin normal in Wilson's disease?
Chowrimootoo GF; Seymour CA
Biochem Soc Trans; 1994 May; 22(2):191S. PubMed ID: 7958254
[No Abstract] [Full Text] [Related]
32. Pigmented corneal rings in non-Wilsonian liver disease.
Fleming CR; Dickson ER; Wahner HW; Hollenhorst RW; McCall JT
Ann Intern Med; 1977 Mar; 86(3):285-8. PubMed ID: 842986
[TBL] [Abstract][Full Text] [Related]
33. Studies on copper, caeruloplasmin and cirrhosis in relation to Wilson's disease.
Williams AO
Br J Exp Pathol; 1965 Oct; 46(5):564-8. PubMed ID: 5838405
[No Abstract] [Full Text] [Related]
34. Striking variability of hepatic copper levels in fulminant hepatic failure.
McDonald JA; Snitch P; Painter D; Hensley W; Gallagher ND; McCaughan GW
J Gastroenterol Hepatol; 1992; 7(4):396-8. PubMed ID: 1515566
[TBL] [Abstract][Full Text] [Related]
35. Does orthotopic liver transplantation normalize copper metabolism in patients with Wilson's disease?
Diaz J; Acosta F; Cañizares F; Bueno FS; Tornel PL; Tovar I; Contreras RF; Marquez M; Martinez P; Parrilla P
Transplant Proc; 1995 Aug; 27(4):2306. PubMed ID: 7652819
[No Abstract] [Full Text] [Related]
36. The significance of variations in the distribution of copper in liver disease.
Goldfischer S; Popper H; Sternlieb I
Am J Pathol; 1980 Jun; 99(3):715-30. PubMed ID: 7386600
[TBL] [Abstract][Full Text] [Related]
37. Urinary copper excretion and hepatic copper concentrations in liver disease.
Frommer DJ
Digestion; 1981; 21(4):169-78. PubMed ID: 7215719
[TBL] [Abstract][Full Text] [Related]
38. Copper metabolism in patients with liver disease.
Nutr Rev; 1977 Jun; 35(6):136-8. PubMed ID: 327353
[No Abstract] [Full Text] [Related]
39. Effect of D-penicillamine on copper retention in patients with primary billiary cirrhosis.
Deering TB; Dickson ER; Fleming CR; Geall MG; McCall JT; Baggenstoss AH
Gastroenterology; 1977 Jun; 72(6):1208-12. PubMed ID: 870369
[TBL] [Abstract][Full Text] [Related]
40. Hepatic lysosomal copper-thionein.
Sternlieb I
Experientia Suppl; 1987; 52():647-53. PubMed ID: 2959558
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
